Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models

Yisheng Jiang, Yongqiang Deng, Huanhuan Pang, Tiantian Ma, Qing Ye, Qi Chen, Haiyang Chen, Zeping Hu, Cheng Feng Qin, Zhiheng Xu

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


The global COVID-19 epidemic has spread rapidly around the world and caused the death of more than 5 million people. It is urgent to develop effective strategies to treat COVID-19 patients. Here, we revealed that SARS-CoV-2 infection resulted in the dysregulation of genes associated with NAD+ metabolism, immune response, and cell death in mice, similar to that in COVID-19 patients. We therefore investigated the effect of treatment with NAD+ and its intermediate (NMN) and found that the pneumonia phenotypes, including excessive inflammatory cell infiltration, hemolysis, and embolization in SARS-CoV-2-infected lungs were significantly rescued. Cell death was suppressed substantially by NAD+ and NMN supplementation. More strikingly, NMN supplementation can protect 30% of aged mice infected with the lethal mouse-adapted SARS-CoV-2 from death. Mechanically, we found that NAD+ or NMN supplementation partially rescued the disturbed gene expression and metabolism caused by SARS-CoV-2 infection. Thus, our in vivo mouse study supports trials for treating COVID-19 patients by targeting the NAD+ pathway.

Original languageEnglish (US)
Article number38
JournalCell Discovery
Issue number1
StatePublished - Dec 2022
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Genetics
  • Cell Biology


Dive into the research topics of 'Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models'. Together they form a unique fingerprint.

Cite this